ZebiAI Therapeutics
Chestnut Hill, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into ZebiAI Therapeutics
Sign up to see every warm intro you have to ZebiAI Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ZebiAI Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 1
Anterra CapitalreportedAmsterdam · $20M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2019
▶$10MraisedJan 2020 · 6 investors · Other TechnologyRule 506(b)
▶$10MraisedJan 2020 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brant C. BinderExecutive Officer, Director
- Philip AustinDirector
- Richard WagnerDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through ZebiAI Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are ZebiAI Therapeutics's investors?
- ZebiAI Therapeutics's investors include Anterra Capital.
- How much funding has ZebiAI Therapeutics raised?
- ZebiAI Therapeutics has disclosed $10M raised across 1 round.
- Where is ZebiAI Therapeutics headquartered?
- ZebiAI Therapeutics is headquartered in Chestnut Hill, US.

